Jeff Lagasse
Readmissions occur for almost 20 percent of patients hospitalized in the U.S. and are associated with patient harm and expenses.
Consumer and employee expectations are changing, requiring continued investment in technology from health leaders.
The Rhode Island governor has asked Lifespan, Care New England and Brown University to resume negotiations for an academic medical center.
Consumers are also interested in technologies that will help them manage their health and engage with physicians.
The majority of providers are concerned about drug diversion in hospitals, but only 20 percent believe diversion is cause for concern where they work.
The current rebate system plays a central role driving up costs for consumers, preventing them from making informed decisions, study says.
Most hospital board members are male and white, and younger members are rare, but some of these trends are changing.
An additional 355,184 people would have been screened for colorectal cancer if non-expansion states had seen the same increases in screenings.
Fewer than one in five are currently receiving information on how to avoid, manage, or mitigate the effects of a costly condition.
Targeted interventions have shown a modest ability to lower costs and have the potential to greatly improve cancer care.